Advanced Biomed Inc. ADVB
6.38
0.07
1.11%
as of 25 Sep
- Market cap
- $10.4M
- P/E
- 1.3×
Follow ADVB
| Older periods | Jun '25 | Sep '25 | Dec '25 | Mar '26 | |
|---|---|---|---|---|---|
Current Ratio |
+6 more quarters Free account |
1.31 | 1.92 | 8.56 | 7.38 |
Net Debt/EBITDA |
2.08 | 5.58 | 6.36 | 5.10 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
2.20 | 1.58 | (0.07) | 0.49 | |
Capex/Depreciation |
(0.07) | (0.04) | 1.00 | (0.13) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(1.52) | (0.57) | (0.49) | (0.19) | |
Cash per Share |
2.79 | 2.46 | 2.41 | 2.03 | |
Shareholders Equity per Share |
3.39 | 2.78 | 8.76 | 7.17 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
3.39 | 2.78 | 8.76 | 7.17 | |
Free Cash Flow |
(1.56) | (0.61) | (0.53) | (0.24) | |
Working Capital |
3.14 | 2.80 | 9.48 | 9.10 | |
Capital Expenditures |
(0.02) | 0.00 | (0.01) | 0.00 | |
Net Current Asset Value |
3.00 | 2.61 | 9.36 | 9.09 | |
| Other line items | |||||
Quick Ratio |
0.28 | 0.87 | 2.08 | 1.83 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(1.50) | (0.56) | (0.47) | (0.19) | |
Capex per Share |
(0.02) | 0.00 | (0.01) | 0.00 | |
Average Payables |
— | 2.84 | 2.41 | 2.69 | |
Average Assets |
6.86 | 3.12 | 7.68 | 9.47 | |
Average Common Equity |
— | 2.33 | 5.05 | 6.67 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates